APO Research

APO RESEARCH · REPORT

Digestive System Antacids

Selected research

Industry Research

Digestive System Antacids Industry Research Report 2026

Market perspective

The global Digestive System Antacids market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Digestive System Antacids is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Digestive System Antacids is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Digestive System Antacids is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Digestive System Antacids include Huasen Pharma, Takeda Pharmaceutical, Sanofi, Pfizer, CR SANJIU, GlaxoSmithKline, Bayer, AstraZeneca and Reddy'sLaboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Digestive System Antacids market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Digestive System Antacids Market by Company

Huasen Pharma

Takeda Pharmaceutical

Sanofi

Pfizer

CR SANJIU

GlaxoSmithKline

Bayer

AstraZeneca

Reddy'sLaboratories

Reckitt Benckiser

Procter&Gamble

Johnson&Johnson

CONBA

Bausch Health

Almirall

Digestive System Antacids Segment by Type

Sodium Bicarbonate Tablets

Magnesium Aluminum Carbonate Tablets

Aluminum Phosphate Gel

Compound Aluminum Hydroxide Tablets

Other

Digestive System Antacids Segment by Application

OTC Drug

Rx Drug

Digestive System Antacids Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digestive System Antacids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digestive System Antacids and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digestive System Antacids.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Digestive System Antacids manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Digestive System Antacids by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Digestive System Antacids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Digestive System Antacids Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Digestive System Antacids Sales (k units) of Manufacturers (2021-2026) Table 7. Global Digestive System Antacids Sales Market Share by Manufacturers (2021-2026) Table 8. Global Digestive System Antacids Revenue of Manufacturers (2021-2026) Table 9. Global Digestive System Antacids Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Digestive System Antacids Average Price (USD/unit) of Manufacturers (2021-2026) Table 11. Global Digestive System Antacids Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Digestive System Antacids, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Digestive System Antacids, Product Type & Application Table 14. Global Digestive System Antacids Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Digestive System Antacids by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Huasen Pharma Company Information Table 19. Huasen Pharma Business Overview Table 20. Huasen Pharma Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 21. Huasen Pharma Digestive System Antacids Product Portfolio Table 22. Huasen Pharma Recent Developments Table 23. Takeda Pharmaceutical Company Information Table 24. Takeda Pharmaceutical Business Overview Table 25. Takeda Pharmaceutical Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 26. Takeda Pharmaceutical Digestive System Antacids Product Portfolio Table 27. Takeda Pharmaceutical Recent Developments Table 28. Sanofi Company Information Table 29. Sanofi Business Overview Table 30. Sanofi Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 31. Sanofi Digestive System Antacids Product Portfolio Table 32. Sanofi Recent Developments Table 33. Pfizer Company Information Table 34. Pfizer Business Overview Table 35. Pfizer Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 36. Pfizer Digestive System Antacids Product Portfolio Table 37. Pfizer Recent Developments Table 38. CR SANJIU Company Information Table 39. CR SANJIU Business Overview Table 40. CR SANJIU Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 41. CR SANJIU Digestive System Antacids Product Portfolio Table 42. CR SANJIU Recent Developments Table 43. GlaxoSmithKline Company Information Table 44. GlaxoSmithKline Business Overview Table 45. GlaxoSmithKline Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. GlaxoSmithKline Digestive System Antacids Product Portfolio Table 47. GlaxoSmithKline Recent Developments Table 48. Bayer Company Information Table 49. Bayer Business Overview Table 50. Bayer Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 51. Bayer Digestive System Antacids Product Portfolio Table 52. Bayer Recent Developments Table 53. AstraZeneca Company Information Table 54. AstraZeneca Business Overview Table 55. AstraZeneca Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 56. AstraZeneca Digestive System Antacids Product Portfolio Table 57. AstraZeneca Recent Developments Table 58. Reddy'sLaboratories Company Information Table 59. Reddy'sLaboratories Business Overview Table 60. Reddy'sLaboratories Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Reddy'sLaboratories Digestive System Antacids Product Portfolio Table 62. Reddy'sLaboratories Recent Developments Table 63. Reckitt Benckiser Company Information Table 64. Reckitt Benckiser Business Overview Table 65. Reckitt Benckiser Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Reckitt Benckiser Digestive System Antacids Product Portfolio Table 67. Reckitt Benckiser Recent Developments Table 68. Procter&Gamble Company Information Table 69. Procter&Gamble Business Overview Table 70. Procter&Gamble Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Procter&Gamble Digestive System Antacids Product Portfolio Table 72. Procter&Gamble Recent Developments Table 73. Johnson&Johnson Company Information Table 74. Johnson&Johnson Business Overview Table 75. Johnson&Johnson Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Johnson&Johnson Digestive System Antacids Product Portfolio Table 77. Johnson&Johnson Recent Developments Table 78. CONBA Company Information Table 79. CONBA Business Overview Table 80. CONBA Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. CONBA Digestive System Antacids Product Portfolio Table 82. CONBA Recent Developments Table 83. Bausch Health Company Information Table 84. Bausch Health Business Overview Table 85. Bausch Health Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Bausch Health Digestive System Antacids Product Portfolio Table 87. Bausch Health Recent Developments Table 88. Almirall Company Information Table 89. Almirall Business Overview Table 90. Almirall Digestive System Antacids Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Almirall Digestive System Antacids Product Portfolio Table 92. Almirall Recent Developments Table 93. Global Digestive System Antacids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Digestive System Antacids Sales by Region (2021-2026) & (k units) Table 95. Global Digestive System Antacids Sales Market Share by Region (2021-2026) Table 96. Global Digestive System Antacids Sales by Region (2027-2032) & (k units) Table 97. Global Digestive System Antacids Sales Market Share by Region (2027-2032) Table 98. Global Digestive System Antacids Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Digestive System Antacids Revenue Market Share by Region (2021-2026) Table 100. Global Digestive System Antacids Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Digestive System Antacids Revenue Market Share by Region (2027-2032) Table 102. North America Digestive System Antacids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Digestive System Antacids Sales by Country (2021-2026) & (k units) Table 104. North America Digestive System Antacids Sales by Country (2027-2032) & (k units) Table 105. North America Digestive System Antacids Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Digestive System Antacids Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Digestive System Antacids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Digestive System Antacids Sales by Country (2021-2026) & (k units) Table 109. Europe Digestive System Antacids Sales by Country (2027-2032) & (k units) Table 110. Europe Digestive System Antacids Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Digestive System Antacids Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Digestive System Antacids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Digestive System Antacids Sales by Country (2021-2026) & (k units) Table 114. Asia Pacific Digestive System Antacids Sales by Country (2027-2032) & (k units) Table 115. Asia Pacific Digestive System Antacids Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Digestive System Antacids Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Digestive System Antacids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Digestive System Antacids Sales by Country (2021-2026) & (k units) Table 119. South America Digestive System Antacids Sales by Country (2027-2032) & (k units) Table 120. South America Digestive System Antacids Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Digestive System Antacids Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Digestive System Antacids Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Digestive System Antacids Sales by Country (2021-2026) & (k units) Table 124. Middle East and Africa Digestive System Antacids Sales by Country (2027-2032) & (k units) Table 125. Middle East and Africa Digestive System Antacids Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Digestive System Antacids Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Digestive System Antacids Sales by Type (2021-2026) & (k units) Table 128. Global Digestive System Antacids Sales by Type (2027-2032) & (k units) Table 129. Global Digestive System Antacids Sales Market Share by Type (2021-2026) Table 130. Global Digestive System Antacids Sales Market Share by Type (2027-2032) Table 131. Global Digestive System Antacids Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Digestive System Antacids Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Digestive System Antacids Revenue Market Share by Type (2021-2026) Table 134. Global Digestive System Antacids Revenue Market Share by Type (2027-2032) Table 135. Global Digestive System Antacids Price by Type (2021-2026) & (USD/unit) Table 136. Global Digestive System Antacids Price by Type (2027-2032) & (USD/unit) Table 137. Global Digestive System Antacids Sales by Application (2021-2026) & (k units) Table 138. Global Digestive System Antacids Sales by Application (2027-2032) & (k units) Table 139. Global Digestive System Antacids Sales Market Share by Application (2021-2026) Table 140. Global Digestive System Antacids Sales Market Share by Application (2027-2032) Table 141. Global Digestive System Antacids Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Digestive System Antacids Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Digestive System Antacids Revenue Market Share by Application (2021-2026) Table 144. Global Digestive System Antacids Revenue Market Share by Application (2027-2032) Table 145. Global Digestive System Antacids Price by Application (2021-2026) & (USD/unit) Table 146. Global Digestive System Antacids Price by Application (2027-2032) & (USD/unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Digestive System Antacids Distributors List Table 150. Digestive System Antacids Customers List Table 151. Digestive System Antacids Industry Trends Table 152. Digestive System Antacids Industry Drivers Table 153. Digestive System Antacids Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Digestive System Antacids Product Image Figure 5. Global Digestive System Antacids Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Digestive System Antacids Market Size (2021-2032) & (US$ Million) Figure 7. Global Digestive System Antacids Sales (2021-2032) & (k units) Figure 8. Global Digestive System Antacids Average Price (USD/unit) & (2021-2032) Figure 9. Sodium Bicarbonate Tablets Product Image Figure 10. Magnesium Aluminum Carbonate Tablets Product Image Figure 11. Aluminum Phosphate Gel Product Image Figure 12. Compound Aluminum Hydroxide Tablets Product Image Figure 13. Other Product Image Figure 14. OTC Drug Product Image Figure 15. Rx Drug Product Image Figure 16. Global Digestive System Antacids Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Digestive System Antacids, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Digestive System Antacids Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Digestive System Antacids Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Digestive System Antacids Sales by Region in 2025 Figure 22. Global Digestive System Antacids Revenue by Region in 2025 Figure 23. North America Digestive System Antacids Market Size by Country in 2025 Figure 24. North America Digestive System Antacids Sales Market Share by Country (2021-2032) Figure 25. North America Digestive System Antacids Revenue Market Share by Country (2021-2032) Figure 26. United States Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Digestive System Antacids Market Size by Country in 2025 Figure 30. Europe Digestive System Antacids Sales Market Share by Country (2021-2032) Figure 31. Europe Digestive System Antacids Revenue Market Share by Country (2021-2032) Figure 32. Germany Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Digestive System Antacids Market Size by Country in 2025 Figure 43. Asia Pacific Digestive System Antacids Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Digestive System Antacids Revenue Market Share by Country (2021-2032) Figure 45. China Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Digestive System Antacids Market Size by Country in 2025 Figure 54. South America Digestive System Antacids Sales Market Share by Country (2021-2032) Figure 55. South America Digestive System Antacids Revenue Market Share by Country (2021-2032) Figure 56. Brazil Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Digestive System Antacids Market Size by Country in 2025 Figure 60. Middle East and Africa Digestive System Antacids Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Digestive System Antacids Revenue Market Share by Country (2021-2032) Figure 62. Egypt Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Digestive System Antacids Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Digestive System Antacids Sales Market Share by Type (2021-2032) Figure 68. Global Digestive System Antacids Revenue Market Share by Type (2021-2032) Figure 69. Global Digestive System Antacids Price (USD/unit) by Type (2021-2032) Figure 70. Global Digestive System Antacids Sales Market Share by Application (2021-2032) Figure 71. Global Digestive System Antacids Revenue Market Share by Application (2021-2032) Figure 72. Global Digestive System Antacids Price (USD/unit) by Application (2021-2032) Figure 73. Digestive System Antacids Value Chain Figure 74. Digestive System Antacids Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Digestive System Antacids Industry Opportunities and Challenges

Scope & coverage.

Types
  • Sodium Bicarbonate Tablets
  • Magnesium Aluminum Carbonate Tablets
  • Aluminum Phosphate Gel
  • Compound Aluminum Hydroxide Tablets
  • Other
Applications
  • OTC Drug
  • Rx Drug
Companies covered
  • Huasen Pharma
  • Takeda Pharmaceutical
  • Sanofi
  • Pfizer
  • CR SANJIU
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • Reddy'sLaboratories
  • Reckitt Benckiser
  • Procter&Gamble
  • Johnson&Johnson
  • CONBA
  • Bausch Health
  • Almirall

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Digestive System Antacids Market Size (2021-2032)
  4. 2.2.2 Global Digestive System Antacids Sales (2021-2032)
  5. 2.2.3 Global Digestive System Antacids Market Average Price (2021-2032)
  6. 2.3 Digestive System Antacids by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Sodium Bicarbonate Tablets
  9. 2.3.3 Magnesium Aluminum Carbonate Tablets
  10. 2.3.4 Aluminum Phosphate Gel
  11. 2.3.5 Compound Aluminum Hydroxide Tablets
  12. 2.3.6 Other
  13. 2.4 Digestive System Antacids by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 OTC Drug
  16. 2.4.3 Rx Drug
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Digestive System Antacids Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Digestive System Antacids Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Digestive System Antacids Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Digestive System Antacids Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Digestive System Antacids Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Digestive System Antacids, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Digestive System Antacids, Product Type & Application
  8. 3.8 Global Manufacturers of Digestive System Antacids, Established Date
  9. 3.9 Global Digestive System Antacids Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Huasen Pharma
  2. 4.1.1 Huasen Pharma Company Information
  3. 4.1.2 Huasen Pharma Business Overview
  4. 4.1.3 Huasen Pharma Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Huasen Pharma Digestive System Antacids Product Portfolio
  6. 4.1.5 Huasen Pharma Recent Developments
  7. 4.2 Takeda Pharmaceutical
  8. 4.2.1 Takeda Pharmaceutical Company Information
  9. 4.2.2 Takeda Pharmaceutical Business Overview
  10. 4.2.3 Takeda Pharmaceutical Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Takeda Pharmaceutical Digestive System Antacids Product Portfolio
  12. 4.2.5 Takeda Pharmaceutical Recent Developments
  13. 4.3 Sanofi
  14. 4.3.1 Sanofi Company Information
  15. 4.3.2 Sanofi Business Overview
  16. 4.3.3 Sanofi Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Sanofi Digestive System Antacids Product Portfolio
  18. 4.3.5 Sanofi Recent Developments
  19. 4.4 Pfizer
  20. 4.4.1 Pfizer Company Information
  21. 4.4.2 Pfizer Business Overview
  22. 4.4.3 Pfizer Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Digestive System Antacids Product Portfolio
  24. 4.4.5 Pfizer Recent Developments
  25. 4.5 CR SANJIU
  26. 4.5.1 CR SANJIU Company Information
  27. 4.5.2 CR SANJIU Business Overview
  28. 4.5.3 CR SANJIU Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 CR SANJIU Digestive System Antacids Product Portfolio
  30. 4.5.5 CR SANJIU Recent Developments
  31. 4.6 GlaxoSmithKline
  32. 4.6.1 GlaxoSmithKline Company Information
  33. 4.6.2 GlaxoSmithKline Business Overview
  34. 4.6.3 GlaxoSmithKline Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 GlaxoSmithKline Digestive System Antacids Product Portfolio
  36. 4.6.5 GlaxoSmithKline Recent Developments
  37. 4.7 Bayer
  38. 4.7.1 Bayer Company Information
  39. 4.7.2 Bayer Business Overview
  40. 4.7.3 Bayer Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Bayer Digestive System Antacids Product Portfolio
  42. 4.7.5 Bayer Recent Developments
  43. 4.8 AstraZeneca
  44. 4.8.1 AstraZeneca Company Information
  45. 4.8.2 AstraZeneca Business Overview
  46. 4.8.3 AstraZeneca Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 AstraZeneca Digestive System Antacids Product Portfolio
  48. 4.8.5 AstraZeneca Recent Developments
  49. 4.9 Reddy'sLaboratories
  50. 4.9.1 Reddy'sLaboratories Company Information
  51. 4.9.2 Reddy'sLaboratories Business Overview
  52. 4.9.3 Reddy'sLaboratories Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Reddy'sLaboratories Digestive System Antacids Product Portfolio
  54. 4.9.5 Reddy'sLaboratories Recent Developments
  55. 4.10 Reckitt Benckiser
  56. 4.10.1 Reckitt Benckiser Company Information
  57. 4.10.2 Reckitt Benckiser Business Overview
  58. 4.10.3 Reckitt Benckiser Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Reckitt Benckiser Digestive System Antacids Product Portfolio
  60. 4.10.5 Reckitt Benckiser Recent Developments
  61. 4.11 Procter&Gamble
  62. 4.11.1 Procter&Gamble Company Information
  63. 4.11.2 Procter&Gamble Business Overview
  64. 4.11.3 Procter&Gamble Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Procter&Gamble Digestive System Antacids Product Portfolio
  66. 4.11.5 Procter&Gamble Recent Developments
  67. 4.12 Johnson&Johnson
  68. 4.12.1 Johnson&Johnson Company Information
  69. 4.12.2 Johnson&Johnson Business Overview
  70. 4.12.3 Johnson&Johnson Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Johnson&Johnson Digestive System Antacids Product Portfolio
  72. 4.12.5 Johnson&Johnson Recent Developments
  73. 4.13 CONBA
  74. 4.13.1 CONBA Company Information
  75. 4.13.2 CONBA Business Overview
  76. 4.13.3 CONBA Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 CONBA Digestive System Antacids Product Portfolio
  78. 4.13.5 CONBA Recent Developments
  79. 4.14 Bausch Health
  80. 4.14.1 Bausch Health Company Information
  81. 4.14.2 Bausch Health Business Overview
  82. 4.14.3 Bausch Health Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Bausch Health Digestive System Antacids Product Portfolio
  84. 4.14.5 Bausch Health Recent Developments
  85. 4.15 Almirall
  86. 4.15.1 Almirall Company Information
  87. 4.15.2 Almirall Business Overview
  88. 4.15.3 Almirall Digestive System Antacids Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Almirall Digestive System Antacids Product Portfolio
  90. 4.15.5 Almirall Recent Developments
5 Global Digestive System Antacids Market Scenario by Region
  1. 5.1 Global Digestive System Antacids Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Digestive System Antacids Sales by Region: 2021-2032
  3. 5.2.1 Global Digestive System Antacids Sales by Region: 2021-2026
  4. 5.2.2 Global Digestive System Antacids Sales by Region: 2027-2032
  5. 5.3 Global Digestive System Antacids Revenue by Region: 2021-2032
  6. 5.3.1 Global Digestive System Antacids Revenue by Region: 2021-2026
  7. 5.3.2 Global Digestive System Antacids Revenue by Region: 2027-2032
  8. 5.4 North America Digestive System Antacids Market Facts & Figures by Country
  9. 5.4.1 North America Digestive System Antacids Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Digestive System Antacids Sales by Country (2021-2032)
  11. 5.4.3 North America Digestive System Antacids Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Digestive System Antacids Market Facts & Figures by Country
  16. 5.5.1 Europe Digestive System Antacids Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Digestive System Antacids Sales by Country (2021-2032)
  18. 5.5.3 Europe Digestive System Antacids Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Digestive System Antacids Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Digestive System Antacids Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Digestive System Antacids Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Digestive System Antacids Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Digestive System Antacids Market Facts & Figures by Country
  41. 5.7.1 South America Digestive System Antacids Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Digestive System Antacids Sales by Country (2021-2032)
  43. 5.7.3 South America Digestive System Antacids Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Digestive System Antacids Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Digestive System Antacids Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Digestive System Antacids Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Digestive System Antacids Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Digestive System Antacids Sales by Type (2021-2032)
  2. 6.1.1 Global Digestive System Antacids Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Digestive System Antacids Sales Market Share by Type (2021-2032)
  4. 6.2 Global Digestive System Antacids Revenue by Type (2021-2032)
  5. 6.2.1 Global Digestive System Antacids Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Digestive System Antacids Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Digestive System Antacids Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Digestive System Antacids Sales by Application (2021-2032)
  2. 7.1.1 Global Digestive System Antacids Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Digestive System Antacids Sales Market Share by Application (2021-2032)
  4. 7.2 Global Digestive System Antacids Revenue by Application (2021-2032)
  5. 7.2.1 Global Digestive System Antacids Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Digestive System Antacids Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Digestive System Antacids Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Digestive System Antacids Value Chain Analysis
  2. 8.1.1 Digestive System Antacids Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Digestive System Antacids Production Mode & Process
  5. 8.2 Digestive System Antacids Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Digestive System Antacids Distributors
  8. 8.2.3 Digestive System Antacids Customers
9 Global Digestive System Antacids Analyzing Market Dynamics
  1. 9.1 Digestive System Antacids Industry Trends
  2. 9.2 Digestive System Antacids Industry Drivers
  3. 9.3 Digestive System Antacids Industry Opportunities and Challenges
  4. 9.4 Digestive System Antacids Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research